Industry: Pharmaceuticals & Biotech•
Not Specified years
Posted 32 days ago
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we'll help you build a career that you can feel passionate about.
We are seeking a Clinical Pathologist II, located in Reno NV. Charles River Laboratories Nevada employs a multidisciplinary group of scientists and technical staff that conduct investigative and IND-enabling preclinical studies in non-human primates and rats for drug development for pharmaceutical companies. The clinical pathology laboratory is equipped for hematology, clinical chemistry, coagulation, urinalysis and other specialty analyses. The successful candidate will join locally a staff of board-certified clinical pathologists, a laboratory staffed by multiple medical technologists, about 20 support technicians, and a global group of 15 board-certified clinical pathologists located in the U.S., Canada and France.
The following are responsibilities related to the Clinical Pathologist II:
• Partner with Study Directors to provide comprehensive interpretation and preparation of the clinical pathology portions of reports.
• Participate in protocol development, measurement of hematology, coagulation, clinical chemistry, and urinalysis parameters.
• Responsible for the collection and reporting of clinical pathology data in studies. Provide assistance to Study Directors in the interpretation of clinical pathology endpoints.
• Serve as Study Director and Pathologist on studies, as assigned, within the Clinical Pathology department.
• Responsible for preparation of assigned clinical pathology reports. Work with the Study Director to ensure that the data is accurately integrated into the final study report.
• Interact with Anatomic Pathologists to ensure relevant and appropriate correlations for clinical and anatomical pathology endpoints.
• Evaluate study products related to clinical pathology, such as blood smears, bone marrow smears, urinalysis sediment preparations, and body fluid preparations. Evaluate other materials as necessary and appropriate.
The following are minimum qualifications related to the Clinical Pathologist II position:
• Education: D.V.M. / V.M.D. (Doctor of Veterinary Medicine) degree required. Ph.D. in Clinical Pathology or related discipline preferred.
• Experience: Experience in clinical pathology or experimental pathology preferred.
• Certification/Licensure: Board certification by the American College of Veterinary Pathologists (D.A.C.V.P.) Specialty in Clinical Pathology required.
• Other: Full understanding of regulatory requirements, Good Laboratory Practices (GLPs), site SOPs, and of study types assigned. Knowledge of applicable international guidelines for all types of toxicology studies. Demonstrate leadership skills as they pertain to intra- and interdepartmental initiatives, Sponsor interactions, and business development.
Charles River Laboratories–Nevada is located in Reno, Nevada and is approximately 45 minutes from Lake Tahoe.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients' clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 14,000 employees within 80 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client's unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2018, revenue increased by 22% to $2.27 billion from $1.86 billion in 2017.
At Charles River, we are passionate about our role in improving the quality of people's lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2018.